News
Researchers analyzed long-term survival of women diagnosed with low-risk cervical cancer, from 2010 through 2017, who ...
The company is working closely with the contract manufacturing facility for resumption of operations. Shares of ...
ICICI Securities recommended reduce rating on GlaxoSmithKline Pharmaceuticals with a target price of Rs 2,600 in its research ...
The NIFTY MIDCAP 150's movements reflect ongoing market dynamics, with Global Health, JSW Infra, and GlaxoSmithKline ...
Amagi is planning to raise Rs 3,200 crore through public listing, and has appointed Kotak Mahindra Capital, Citigroup, IIFL ...
U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research ...
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...
A kidnapped child, a husband with a double life, a treacherous murder plot unraveled when the police arrive at the perfect ...
1h
Zacks Investment Research on MSNPharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New DealsBayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller ...
AstraZeneca and British American Tobacco today provided fresh support for the FTSE 100 index at the end of a positive week ...
Merck’s Keytruda, with more than 40 approved indications, hasn’t yet been able to crack specifically into ovarian cancer. | ...
Drugmaker Abbott India reported a 28% rise in fourth-quarter profit on Thursday, helped by strong demand for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results